Hyperfine, Inc. (HYPR) stock
Close on Nov 12, 2026Market cap $72.04MP/E –Yield –
Hyperfine, Inc. grew revenue 80.0% to $19.06M over the twelve months to Sep 30, 2026. Free cash flow was -$27.92M. At the latest close the market valued the company at $72.04M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $72.04M
- P/E ratio
- –
- Price to sales
- 3.78
- Price to book
- 2.27
- Dividend yield
- –
- Free cash flow yield
- -38.76%
Fundamentals
- Revenue
- $19.06M
- Net income
- -$29.81M
- EPS, diluted
- -$0.30
- Free cash flow
- -$27.92M
- Book value per share
- $0.30
- Diluted shares
- 106M
Trading
- Next earnings
- Mar 17, 2027 (estimated, after the close)
- Previous close
- $0.71
- Open
- $0.69
- Day's range
- $0.67 – $0.70
- Volume
- 498,461
- Average volume (20 days)
- 531,944
- Index membership
- Russell 2000 (since Jun 2026)
- Beta (5 years)
- 1.05
- 52-week range
- $0.67 – $1.94
- RSI (14 days)
- 44.1
- Volatility (1 year)
- 70.8%
- Relative volume
- 0.50×
- WACC
- 9.4%
Index membership is inferred from the holdings of funds that track each index (IWM), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2021, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | HYPR | S&P 500 | Difference | HYPR per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -25.1% | -2.7% | −22.4 pts | ||
| 3 months | -24.6% | -1.7% | −22.8 pts | ||
| Year to date | -30.6% | +11.9% | −42.5 pts | ||
| 1 year | -38.2% | +12.0% | −50.2 pts | ||
| 3 years | -34.0% | +78.2% | −112.2 pts | -13.0% | +21.2% |
| 5 years | -93.2% | +73.2% | −166.4 pts | -41.6% | +11.6% |
Seven years at a glance
Fiscal years 2019 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Hyperfine filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
About Hyperfine
Electromedical & Electrotherapeutic Apparatus
The health technology company develops and commercializes artificial intelligence-powered portable magnetic resonance imaging solutions. Its principal offering is the Swoop Portable MR Imaging System, an ultra-low-field brain scanner integrated with deep learning software designed to deliver neuroimaging directly at the point of care, including bedside hospital settings and outpatient clinics. Operating alongside the scanner hardware, the business provides proprietary software sequences, annual service agreements, and a subscription-based research data platform. The company primarily serves healthcare providers, including critical care units, emergency departments, inpatient hospital facilities, and office-based neurology practices, as well as international clinical providers.
Company profile, executives and historyHyperfine stock: common questions
What is Hyperfine's stock price?
HYPR closed at $0.68 on Nov 12, 2026, down 4.50% on the day. Over the past 52 weeks it traded between $0.67 and $1.94.
What is Hyperfine's market cap?
Hyperfine was worth $72.04M at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is HYPR's P/E ratio?
Hyperfine lost money over the twelve months to Sep 30, 2026 (diluted EPS -$0.30), so it has no meaningful P/E ratio.
How much revenue does Hyperfine make?
Hyperfine reported revenue of $19.06M for the twelve months to Sep 30, 2026, up 80.0% from a year earlier.
Does Hyperfine pay a dividend?
No. Hyperfine has not paid a cash dividend over the last twelve months.
When does Hyperfine report earnings next?
Hyperfine is expected to report Q4 FY2026 results on Mar 17, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has HYPR stock performed over the past year?
Including dividends, HYPR returned -38.2% over the past year, against +12.0% for the S&P 500.
How many HYPR shares are sold short?
4M shares were sold short at the latest FINRA report, 4.54% of the float, or 8.0 days of average trading volume.
Who are Hyperfine's competitors?
Companies most similar to Hyperfine by business, industry and size include QTI, CV, CBLL, PROF, ESMC.
See a number that looks wrong?